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Instructions For AuthorsThe Journal of the American College of Cardiology (JACC) publishes peer-re-
viewed articles highlighting all aspects of cardiovascular disease, including
original clinical studies, experimental investigations with clear clinical rele-
vance, state-of-the-art papers, and viewpoints. In general, case reports will
not be considered for publication.
We request that all manuscripts be submitted online atwww.jaccsubmit.org.
If the manuscript absolutely cannot be submitted online, please contact the
editorial ofﬁce at jaccsd@acc.org.
Manuscript submissions should conform to the guidelines set forth in
the ‘‘Recommendations for the Conduct, Reporting, Editing and Publication
ofScholarlyWork inMedical Journals (ICMJERecommendations),’’available
from http://www.ICMJE.org and most recently updated in 2013.
English language help service: Upon request, Elsevier will direct authors
to an agent who can check and improve the English of their paper (before
submission). Please contact authorsupport@elsevier.com for further
information.
AUTHOR ENQUIRIES
For enquiries relating to submitted articles or to articles currently under
review, please contact the JACC editorial ofﬁce at jaccsd@acc.org.
For information on articles that have been accepted for publication,
please visit Elsevier’s Authors Home at www.elsevier.com/authors.
Elsevier’s Authors Home also provides the facility to track accepted arti-
cles and set up e-mail alerts to inform you of when an article’s status has
changed, as well as detailed artwork guidelines, copyright information,
frequently asked questions, andmore. Authors can order copies of the issue
in which their article appears at a discounted rate. For this service, please
contact Elsevier Health Sciences Division, Subscription Customer Service,
3251 Riverport Lane, Maryland Heights, MO 63043. Tel: 1-800-654-2452,
E-mail: journalscustomerservice-usa@elsevier.com.
EXCLUSIVE SUBMISSION/PUBLICATION POLICY
The manuscripts are considered for review only under the conditions that
they arenot under consideration elsewhere and that thedata presentedhave
not appeared on the Internet or have not been previously published
(including symposia, proceedings, transactions, books, articles published
by invitation, and preliminary publications of any kind, excepting abstracts
that do not exceed 400 words). On acceptance, transfer of copyright to the
American College of Cardiology Foundation will be required. Elsevier Inc.
will maintain copyright records for the College.
Only authors appearing on the ﬁnal title page will be sent a form. YOU
CANNOT ADD AUTHORS AFTER ACCEPTANCE OR ON PROOFS. After a
paper is sent to the publisher, the links to the electronic forms will no lon-
ger be active. In this case, authors will be sent links to download hard copy
forms that they may mail or fax to the JACC ofﬁce.
OPEN ACCESS (NEW)
While this journal does not ordinarily have publication charges, authors
can now opt to make their articles available to all (including non-subscrib-
ers) via the ScienceDirect platform, which carries a fee of US $3,000. (For
further information on open access, visit http://www.elsevier.com/about/
open-access/open-access-options). To avoid any perception of conﬂict of
interest, you can only make this choice after receiving notiﬁcation that
your article has been accepted for publication. The fee excludes taxes and
other potential costs such as color charges. In some cases, institutions and
funding bodies have entered into agreement with Elsevier to meet these
fees on behalf of their authors. Details of these agreements are available at
http://www.elsevier.com/fundingbodies. Authors of accepted articles whowish to take advantage of this option should complete and submit the order
form, which is available at http://www.elsevier.com/locate/openaccessform.
pdf. Whatever access option you choose, you retain many rights as an author,
including the right to post a revised personal version of your article on your
ownwebsite. More information can be found here: http://www.elsevier.com/
authorsrights.
Your publication choice will have no effect on the peer review process or
acceptance of submitted articles.
RELATIONSHIP WITH INDUSTRY POLICY
Authors are required to disclose any relationship with industry and ﬁnan-
cial associations within the past 2 years that might pose a conﬂict of
interest in connection with the submitted article on the title page. All
sources of funding for the work should be acknowledged on the title page,
as should all institutional afﬁliations of the authors (including corporate
appointments). This includes associations such as consultancies, stock
ownership, or other equity interests or patent-licensing arrangements. If no
relationship with industry exists, please state this on the title page. Rela-
tionship with industry guidelines apply to all authors.
ALL FORMS ARE NOW SIGNED AND SUBMITTED ELECTRONICALLY.
Once a manuscript is accepted, the authors will be sent links to complete
the electronic Copyright Transfer and Relationship with Industry forms.
Only the corresponding author may electronically sign the copyright form;
however, ALL AUTHORS ARE REQUIRED TO ELECTRONICALLY SIGN A
RELATIONSHIP WITH INDUSTRY FORM. Once completed, a PDF version of
the form is e-mailed to the author. Authors can access and conﬁrm receipt
of forms by logging into their account online. Each author will be alerted
if his form has not been completed by the deadline.
PERMISSIONS
No part of materials published in JACC may be reproduced without written
permission of the publisher. Some materials qualify for gratis usage.
See STM Guidelines for details: http://www.stm-assoc.org/permissions-
guidelines/. Permission may be sought directly from Elsevier’s Global
Rights Department. Phone: 215-239-3804 or 44-1865-843-830. Fax: 44-1865-
853-333. Requests also may be completed online via the Elsevier site
(http://www.elsevier.com/about/policies/author-agreement/obtaining-
permission).
ETHICS
Studies should be in compliance with human studies committees and ani-
mal welfare regulations of the authors’ institutions and the U.S. Food and
Drug Administration guidelines.
Human studies must be performed with the subjects’ written informed
consent. Authors must provide the details of this procedure and indicate
that the institutional committee on human research has approved the
study protocol. If radiation is used in a research procedure, the radiation
exposure must be speciﬁed in the Methods.
Studies on patients or volunteers require ethics committee approval and
informed consent, which should be documented in your paper. Patients
have a right to privacy. Therefore, identifying information, including
patients’ images, names, initials, or hospital numbers, should not be inclu-
ded in videos, recordings, written descriptions, photographs, and pedigrees
unless the information is essential for scientiﬁc purposes, and you have
obtained written informed consent for publication in print and electronic
form from the patient (or parent, guardian, next of kin or other legally
authorized representative). If consent is subject to conditions, the editorial
ofﬁce must be informed.
Written consents must be provided to the editorial ofﬁce on request.
Even where consent has been given, identifying details should be omitted
if they are not essential. If identifying characteristics are altered to protect
anonymity, such as in genetic pedigrees, authors should provide assurance
that alterations do not distort scientiﬁc meaning and editors should so
note. If such consent has not been obtained, personal details of patients
included in any part of the paper and in any supplementary materials
(including all illustrations and videos) must be removed before submission.
Animal investigation must conform to the ‘‘Position of the American
Heart Association on Research Animal Use,’’ adopted by the AHA on
November 11, 1984. If equivalent guidelines are used, they should be indi-
cated. The AHA position includes: 1) animal care and use by qualiﬁed indi-
viduals, supervised by veterinarians, and all facilities and transportation
must comply with current legal requirements and guidelines; 2) research
involving animals should be done only when alternative methods to yield
needed information are not possible; 3) anesthesia must be used in all surgi-
cal interventions, all unnecessary suffering should be avoided and research
must be terminated if unnecessary pain or fear results; and 4) animal facili-
ties must meet the standards of the American Association for Accreditation
of Laboratory Animal Care (AAALAC).
JACC has an ethics committee comprised of 5 cardiologists, which over-
sees quality control and will look into the issues of concern, if any.
AUTHORSHIP/COVER LETTER
Each author must have contributed signiﬁcantly to the submitted work.
The contribution of each must be substantiated in the cover letter. If
authorship is attributed to a group (either solely or in addition to 1 or more
individual authors), all members of the group must meet the full criteria and
requirements for authorship. To save space, if groupmembers have been listed
in JACC, the article should be referenced rather than reprinting the list. The
editors consider authorship to include all of the following: 1) conception and
design or analysis and interpretation of data, or both; 2) drafting of the manu-
script or revising it critically for important intellectual content; and 3) ﬁnal
approval of the manuscript submitted. Participation solely in the collection of
data does not justify authorship but may be appropriately acknowledged in
the Acknowledgment section.
Authors must agree to the following ICJME statements. These questions
will be part of the submission process and manuscripts will not be reviewed
until they are conﬁrmed. 1) The paper is not under consideration elsewhere;
2) none of the paper’s contents with the exception of abstracts have been
previously published; 3) all authors have read and approved themanuscript;
4) agreement to be accountable for all aspects of the work in ensuring
that questions related to the accuracy or integrity of any part of the work
are appropriately investigated and resolved; 5) the full disclosure of
any relationship with industry (see “Relationship with Industry Policy”) or
that no such relationship exists, is stated; and 6) the authors have provided
both an illustration and the appropriate material for inclusion in the box
that appears after the “Conclusions” section in the manuscript. Exceptions
must be explained.
The corresponding author should be speciﬁed in the cover letter. All edi-
torial communications will be sent to this author. The corresponding author
will be whom we contact for submission queries.
A short paragraph telling the editors why the authors think their paper
merits publication priority may be included in the cover letter. Potential
reviewersmay be suggested in the cover letter, as well as reviewers to avoid.
GENERAL GUIDELINES FOR SUBMISSION OF REVIEW ARTICLES
Although the review articles are invited manuscripts, we will happily con-
sider high-caliber proposals. Please submit a pre-submission inquiry beforeyour manuscript. After the manuscript is accepted for publication, the
JACC editors will support the development of the review articles, and the
professional JACC illustrators will redraw illustrations. The review articles
are considered for publication in the following two formats.
1) Present and Future— State-of-the-Art Review: As with all submissions to
JACC, State-of-the-Art Reviews should focus on the patient. From basic
mechanisms to clinical manifestations and interventional approaches to
global health implications, such manuscripts will focus on a contemporary,
controversial, or translational topic with 4-5 major sections written by 4-5
authors (or 4-5 author groups). This should be submitted as 1 single, uniﬁed
paper, and not as 4-5 individual manuscripts. The authors should strictly
adhere to the text length guidelines (a 10,000-word maximum limit for
the entire manuscript, with an unstructured abstract of no more than 150
words). The manuscripts also can be formatted as point-counterpoint
debates. We ask authors to provide a Central Illustration that summarizes
the main concept of the review in a graphical or schematic manner. If the
manuscript is accepted, theﬁnal ﬁgurewill be drawn by an in-housemedical
illustrator. (See further explanation below.)
2) Present and Future— Review Topic of the Week: As with all submissions
to JACC, Review Topics of the Week should focus on the patient. These
articles review a contemporary topic of basic, translational, or clinical sci-
ence. Please e-mail the proposal to the ofﬁce before submitting your paper
(jaccsd@acc.org). Such manuscripts may be written by a single author or
an author group, and requires an unstructured abstract of no more than
150 words. The overall text length should not exceed 5,000 words. We
ask you to provide a Central Illustration (line or pictorial) that summarizes
the main concept of the review. If the manuscript is accepted, the ﬁnal
ﬁgure will be drawn by an in-house medical illustrator. (See further
explanation below.)
GENERAL GUIDELINES FOR
SUBMISSION OF ORIGINAL RESEARCH PAPERS
Because of printed page limitations, manuscripts should not exceed 5,000
words (including references and ﬁgure legends). If you are asked to revise
your paper, the editors may specify an alternate word limit. Illustrations
and tables should be limited to those necessary to highlight key data.
Please provide gender-speciﬁc data, when appropriate, in describing out-
comes of epidemiologic analyses or clinical trials; or speciﬁcally state that
there were no gender-based differences. For original research dealing with
genetic associations, authors should refer to J Am Coll Cardiol 2007;50:930–2.
The manuscript should be arranged as follows: 1) Title page; 2)
Structured Abstract and Key Words; 3) Abbreviations list; 4) Text; 5)
Perspectives: Core Clinical Competencies and Translational Outlook impli-
cations, they are presented on a separate page and will be published in a
box; 6) Acknowledgments (if applicable); 7) References; 8) Figure titles
and legends; 9) Tables. Page numbering should begin with the title page.
Authors are required to present a Central Illustration that summarizes the
main focus of the paper (visual image of the discussion section). This may be
a sketch or a ﬁnished ﬁgure. The JACC staff illustrator can assist you free of
charge in ﬁnishing the ﬁgure, if the paper is accepted for publication.
Expedited Publications. Original manuscripts in this category should report
important original ﬁndings of high-potential clinical impact or research sig-
niﬁcance. They can be either a full-length paper or a short report presenting
early ﬁndings. Authors should request expedited publication in their cover
letter at the time of submission. The editors commit to a decision regar-
ding suitability for expedited publication processing within 2 days, and an
initial decision within 14 days. Those manuscripts not deemed appropriate
for the expedited publication track will be considered according to the
standard review process. We always inform authors whether we are able
to offer expedited review.
MANUSCRIPT CONTENT
TITLE PAGE. Include the title, authors’ names (including full ﬁrst name,
middle initial and degrees), total word count, and a brief title of no more
than 45 characters. List the departments and institutions with which the
authors are afﬁliated, and indicate the speciﬁc afﬁliations if the work is
generated from more than one institution. (Use the footnote symbols given
under “Tables”.) Please list authors’ current email addresses as well. Also
provide information on grants, contracts, and other forms of ﬁnancial sup-
port. List the cities and states of all foundations, funds, and institutions
involved in thework.Thismust include the full disclosureof any relationship
with industry. (See the “Relationship with Industry Policy”.) If there are
no relationships with industry, this should be stated. Under the heading,
“Address for correspondence,” provide the full name and complete postal
address of theauthor towhomcommunications, printer’sproofs, and reprint
requests should be sent. Also provide telephone, fax numbers, and an e-mail
address.
STRUCTURED ABSTRACT. Provide a structured abstract between 250 (min)
to 300 (max) words, presenting essential data in 5 paragraphs introduced
by separate headings in the following order: Background, Objectives,
Methods, Results, and Conclusions. Please notice the change in the
sequence of headings compared to what we used to publish earlier; now
Background precedes Objectives. Use complete sentences. All data in the
abstract also must appear in the manuscript text or tables.
For general information on preparing structured abstracts, see ‘‘Haynes
RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative
abstracts revisited. Ann Intern Med 1990;113:69-76.’’ An unstructured 150-
word abstract should be provided for the review articles.
KEY WORDS. Immediately after the perspectives, provide a maximum of 6
key words, using American spelling and avoiding general and plural terms
and multiple concepts (avoid, for example, ‘and’, ‘of’). Be sparing with
abbreviations. These keywords will be used for indexing purposes, and
therefore should be different then the terms/words already used in the title
of the paper.
TEXT. The text should be structured as Introduction, Methods, Results,
Discussion, and Conclusions. Use headings and subheadings in the
Methods, Results, and, particularly in the Discussion sections. Every
reference, ﬁgure, and table should be cited in the text in numerical order
according to order of mention.
ABBREVIATIONS. To save space in the Journal, up to 10 abbreviations of
common terms (e.g., ECG, PTCA, CABG) or acronyms (GUSTO, SOLVD, TIMI)
may be used throughout the manuscript. On a separate page following the
abstract, list the selected abbreviations and their deﬁnitions (e.g., TEE ¼
transesophageal echocardiography). The editors will determine which
lesser-known terms should not be abbreviated. Consult ‘‘Recommendations
for the Conduct, Reporting, Editing and Publication of Scholarly Work in
Medical Journals (ICMJE Recommendations),’’ available at http://www.
ICMJE.org and most recently updated in 2013, for appropriate use of units
of measure.
STATISTICS. All publishable manuscripts will be reviewed for appropriate-
ness and accuracy of statistical methods and statistical interpretation of
results. We subscribe to the statistics section of the “Recommendations
for the Conduct, Reporting, Editing and Publication of Scholarly Work in
Medical Journals (ICMJE Recommendations),” available at http://www.
ICMJE.org and most recently updated in 2013. In the Methods section,
provide a subsection detailing the statistical methods, including speciﬁcmethods used to summarize the data, methods used for hypothesis testing
(if any), and the level of signiﬁcance used for hypothesis testing. When
using more sophisticated statistical methods (beyond t tests, chi-square,
simple linear regression), specify the statistical package, version number,
and nondefault options used. For more information on statistical review,
see ‘‘Glantz SA. It is all in the numbers. J Am Coll Cardiol 1993;21:835–7.’’
PERSPECTIVES. The authors should delineate clinical competencies and
translational outlook recommendations for their manuscripts. These should
be listed in the manuscript after the Text and before the Acknowledgments
and References. Please review the examples provided below. The com-
petencies describe the implications of the study for current practice. The
translational outlook places the work in a futuristic context, emphasizing
directions for additional research.
Clin ical Competencies. Competency-based learning in cardiovascular
medicine addresses the 6 domains promulgated by the Accreditation
Council on Graduate Medical Education (ACGME) and endorsed by the
American Board of Internal Medicine (Medical Knowledge, Patient Care and
Procedural Skills, Interpersonal and Communication Skills, Systems-Based
Practice, Practice-Based Learning, and Professionalism) (www.acgme.org/
acgmeweb). The ACCF has adopted this format for its competency and
training statements, career milestones, lifelong learning, and educational
programs. The ACCF also has developed tools to assist physicians in assess-
ing, enhancing, and documenting these competencies (http://www.acc.org/
education-and-meetings/maintenance-of-certiﬁcation-information-hub?
w_nav=MN). Authors are asked to consider the clinical implications of their
report and identify applications in one or more these competency domains
that could be used by clinician readers to enhance their competency as pro-
fessional caregivers. This applies not only tophysicians in training, but to the
sustained commitment to education and continuous improvement across
the span of their professional careers.
Translational Outlook. Translating biomedical research from the laboratory
bench, clinical trials, or global observations to the care of individual
patients can expedite discovery of new diagnostic tools and treatments
through multidisciplinary collaboration. Effective translational medicine
facilitates implementation of evolving strategies for prevention and treat-
ment of disease in the community. The Institute of Medicine identiﬁed
two areas needing improvement: testing basic research ﬁndings in properly
designed clinical trials and, once the safety and efﬁcacy of an intervention
has been conﬁrmed, more efﬁciently promulgating its adoption into
standard practice (Sung NS, Crowley WF, Genel M. The meaning of trans-
lational research and why it matters. JAMA 2008;299:3140-8). The National
Institutes of Health (NIH) has recognized the importance of translational
biomedical research, emphasizing multifunctional collaborations between
researchers and clinicians to leverage new technology and accelerate the
delivery of new therapies to patients (www.ncats.nih.gov/about/about.html).
Authors are asked to place their work in the context of the scientiﬁc
continuum, by identifying impediments and challenges requiring further
investigation and anticipating next steps and directions for future
research.
EXAMPLE 1 : For a Clinical Trial [N Engl J Med 2012;367:2375-84]:
PERSPECTIVES
Competency in Medical Knowledge: Coronary artery bypass (CABG) surgery
is the preferred method of revascularization for patients with diabetes and
multivessel coronary artery disease.
Competency in Patient Care: The diabetic patient with coronary symptom-
atology, prior to the diagnostic catheterization, should be made aware that
if multivessel disease is identiﬁed and intervention is indicated, surgical
consultation should be entertained.
Translational Outlook 1: Although this is a relatively short-term study (medi-
an of 3.8 years), longer term follow up of FREEDOM will lead to better under-
standing of the comparative beneﬁt by CABG, speciﬁcally on mortality.
Translational Outlook 2: Compliance to medication is nonsatisfactory
in patients with coronary artery disease. Comparing the compliance of
FREEDOM patients taking a “polypill” approach (including aspirin, statin,
and an angiotensin-converting enzyme inhibitor) with the compliance
of patients treated conventionally with individual agents should be
undertaken.
EXAMPLE 2 : For a Translational Science Study [Nat Med 2014;20:215-9]:
PERSPECTIVES
Competency in Medical Knowledge: Inﬂammation is one of the major deter-
minants of atherosclerotic plaque instability. Positron emission tomog-
raphy with F18-labeled ﬂuorodeoxyglucose (FDG) has been employed for
the identiﬁcation of the macrophages in high-risk patients. Imaging with
mannose, the isomer of glucose, may have an advantage because a subset
of macrophages in high-risk plaques develop mannose receptors.
Translational Outlook 1: Although circulating biomarkers of inﬂammation,
such as hs-CRP, provide reliable information of systemic inﬂammation,
detection of inﬂammation at the plaque level may allow identiﬁcation of
the high-risk plaques.
Translational Outlook 2:Plaque imaging with sugars, although feasible, must
in a randomized fashion investigate whether treatment of individual high-
risk plaques would favorably inﬂuence major adverse outcomes in athero-
sclerotic disease.
EXAMPLE 3 : For aMeta-Analysis or aReviewArticle [Lancet 2014;383:955–62]:
PERSPECTIVES
Competency in Medical Knowledge 1: Selection of antithrombotic therapy
for prevention of thromboembolism in patients with atrial ﬁbrillation
must consider several clinical factors, including the patient’s values and
preferences.
Competency in Medical Knowledge 2: The oral direct thrombin inhibitor,
dabigatran, and factor Xa inhibitors, rivaroxaban, apixaban, and edoxaban
(so-called novel oral anticoagulants or NOACs) avoid the dietary restrictions
and need for routine coagulation monitoring that are cumbersome aspects
of anticoagulation with vitamin K antagonists such as warfarin.
Competency in Patient Care: All 3 NOACs currently approved for clinical
use in the United States represent advances over warfarin because of their
more predictable pharmacological proﬁles, fewer drug interactions, and
considerably lower risk of intracranial bleeding than warfarin, but these
advantages come at greater monetary cost, and there is presently no
approved antidote or validated strategy rapid reversal of anticoagulation
induced by any of the NOACs.
Competency in Interpersonal & Communication Skills: It is important to dis-
cuss the available options with patients who are candidates for the newer
agents.
Translational Outlook 1: The mechanism by which each of the NOACs
evaluated to date cause less intracerebral hemorrhage than well-managed
warfarin anticoagulation requires further investigation.
Translational Outlook 2: Additional research is needed to understand the
safety and efﬁcacy of the NOACs, alone or in combination in patients with
mechanical prosthetic heart valves to overcome the toxicity of this type of
anticoagulation in the limited studies undertaken to date that contraindi-
cate their use in patients who have undergone heart valve replacement
with mechanical prostheses.ACKNOWLEDGMENTS. 100 words or less; anything exceeding this limit
will appear in the online version only. Letters of permission from all in-
dividuals listed in the acknowledgments are the responsibility of the
corresponding author.
OTHER PAPER CATEGORIES
The following information should be noted for these paper types:
Editorial Comments. The editors invite all Editorial Comments published in
the Journal.
Correspondence. A limited number of letters will be published. The letters
are of 2 types, however both types will be published under the heading
Letters. 1) They should have no more than 400 words, including references,
and focus on a speciﬁc article that has appeared in JACC. Letters must
be submitted within 3 months of the print issue date of the article. Please
include the cited article as a reference. We may seek a reply to your letter
from the authors of the original paper and publish together. 2) You also may
submit original research articles of a focused nature as a research letter.
Research letters are limited to a total of 800 words including references
(no more than 5), and to 1 ﬁgure or table. The letters should include
double-spaced type. These papers do not need an abstract.
REFERENCES
Identify references in the text by Arabic numerals in parentheses on the
line. The reference list should be typed double-spaced on pages separate
from the text; references must be numbered consecutively in the order in
which they are mentioned in the text. The references should only include
the ﬁrst 3 authors of any paper, followed by “et al.”
Do not cite personal communications, manuscripts in preparation, or
other unpublished data in the references; these may be cited in the text
in parentheses. Do not cite abstracts that are older than 2 years. Identify
abstracts by the abbreviation ‘‘abstr’’ in parentheses. If letters to the editor
are cited, identify them with the word ‘‘letter’’ in parentheses.
Use Index Medicus (National Library of Medicine) abbreviations for jour-
nal titles. It is important to note that when citing an article from the Journal
of the American College of Cardiology, the correct citation format is J Am Coll
Cardiol.
Use the following style and punctuation for references:
Periodical. List all authors if 6 or fewer, otherwise list the ﬁrst 3 and add et al.
Do not use periods after the authors’ initials. Please provide inclusive page
numbers as in example below.
5. Glantz SA. It is all in the numbers. J Am Coll Cardiol 1993;21:835–7.
Doi-based citation for an article in press. If the ahead-of-print date is known,
provide as in example below.
16. Winchester D, Wen X, Xie L, et al. Evidence for pre-procedural statin
therapy: meta-analysis of randomized trials. J Am Coll Cardiol 2010 Sept 28
[E-pub ahead of print]; http://dx.doi.org/10.1016/j.jacc.2010.09.028.
If the ahead-of-print date is unknown, omit as in example below.
16. Winchester D, Wen X, Xie L, et al. Evidence for pre-procedural statin
therapy: meta-analysis of randomized trials. J Am Coll Cardiol 2010 [E-pub
ahead of print]; http://dx.doi.org/10.1016/j.jacc.2010.09.028.
Chapter in book. Provide author(s), chapter title, editor(s), book title, pub-
lisher location, publisher name, year, and inclusive page numbers.
27. Meidell RS, Gerard RD, Sambrook JF. Molecular biology of thrombolytic
agents. In: Roberts R, editor. Molecular Basis of Cardiology. Cambridge,
MA: Blackwell Scientiﬁc Publications, 1993:295–324.
Book (personal author or authors.) Provide a speciﬁc (not inclusive) page
number.
23. Cohn PF. Silent Myocardial Ischemia and Infarction. 3rd edition. New
York, NY: Marcel Dekker, 1993:33.
Online media. Provide speciﬁc URL address and date information was
accessed.
10. Henkel J. Testicular Cancer: Survival High With Early Treatment. FDA
Consumer magazine [serial online]. January–February 1996. Available at:
http://www.fda.gov/fdac/features/196_test.html. Accessed August 31, 1998.
Material presented at a meeting but not published. Provide authors, pre-
sentation title, full meeting title, meeting dates, and meeting location.
20. Eisenberg J. Market forces and physician workforce reform: why they
may not work. Paper presented at: Annual Meeting of the Association of
Medical Colleges; October 28, 1995; Washington, DC.
ILLUSTRATIONS, FIGURES & FIGURE LEGENDS
FIGURE LEGENDS. All ﬁgures must have a Number, Title, and Caption. The
title should be short and followed by a 2–3 sentence caption. All abbrevi-
ations used in the ﬁgure should be identiﬁed in an alphabetical order
at the end of each legend. All symbols used (arrows, circles, etc.) must
be explained. Figure legends should be typed double-spaced on pages
separate from the text. Figure numbers must correspond with the order
in which they are mentioned in the text.
If previously published ﬁgures are used, written permission from the
original publisher is required. See STM Guidelines for details: http://www.
stmassoc.org/permissions-guidelines. Cite the ﬁgure source in the legend.
ARTWORK. Figures and graphs submitted in electronic format should be
provided in EPS or TIF format. Graphics software, such as Photoshop and
Illustrator, should be used to create the art, but not presentation software
such as Powerpoint, CorelDraw, or Harvard Graphics. Color images must
be at least 300 DPI. Gray scale images should be at least 300 DPI. Line art
(black and white or color) and combinations of gray scale images and line
art should be at least 1200 DPI. Lettering should be of sufﬁcient size to be
legible after reduction for publication. The optimal size is 12 points.
Symbols should be of a similar size. Figures should be no smaller than 13 cm
 18 cm (500 x 700). Decimals, lines, and other details must be strong enough
for reproduction. Use only black and white—not gray—in charts and graphs.
Place crop marks on photomicrographs to show only the essential ﬁeld.
Designate special features with arrows. All symbols, arrows, and lettering
on half-tone illustrations must contrast with the background.
The in-house artist will tweak the ﬁgures and re-size the ﬁgures if needed.
NONELECTRONIC ARTWORK. Upon provisional acceptance, we may
request 2 sets of glossy or laser prints (clean copies will sufﬁce). Two sets of
glossy prints should be provided for all half-tone or color illustrations. All
graphs and line drawings must be professionally prepared on a computer
and reproduced as high-quality laser prints. Indicate the ﬁrst author’s last
name (and the corresponding author’s last name within parentheses, if dif-
ferent) and the ﬁgure number on the back of each ﬁgure, preferably on an
adhesive label. Figure title and caption material must appear in the legend,
not on the ﬁgure.
Note: if we request hardcopies, they will not be returned to authors.
COLOR ARTWORK. There is no fee for the publication of color ﬁgures. Our
Editors encourage authors to submit ﬁgures in color, as we feel it improves
the clarity and visual impact of the images.
CENTRAL ILLUSTRATION. All Original Research Papers, State-of-the-Art
Reviews, and Review Topics of the Week should develop at least 1 CentralIllustration drawing or ﬁgure (that may be a simple/rough hand-drawn ﬁg-
ure), which summarizes the entire manuscript or at least a major section
of the manuscript. Our in-house medical illustrators will create the ﬁnal
printable versions of these ﬁgures in consultation with the authors and
the editors. The purpose of these illustrations is to provide a snapshot of
your paper in a single visual, conceptual manner. This illustration must be
accompanied by a legend.
TABLES
Tables should be typed double-spaced on separate sheets, with the table
number and title centered above the table and explanatory notes below the
table. Use Arabic numbers. Table numbers must correspond with the order
cited in the text.
ALL TABLES MUST HAVE A TITLE.
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displayed via Windows Media Player
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5. If your paper is accepted for publication you may wish to supply the edi-
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